Tag: Global Pharma News
AstraZeneca Licenses Novel Lung Cancer Drug Zegfrovy in $1.5B Global Deal
AstraZeneca announced a exclusive global license agreement with Dizal Pharmaceutical to develop and commercialize Zegfrovy (sunvozertinib), a highly differentiated, oral irreversible EGFR inhibitor designed for targeted lung cancer...
FDA Approves Utebzi for Complicated Urinary Tract Infections
GSK plc and Spero Therapeutics announced that the US Food and Drug Administration (FDA) has approved Utebzi(tebipenem pivoxil). It is indicated for adult patients with complicated urinary tract...
Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats
Novo Nordisk (Novo Nordisk A/S) the Danish multinational pharmaceutical major, earlier this week announced that the company had identified an IT security incident involving unauthorised access to a limited number of internal IT...
FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI
Wockhardt Limited announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic for treating adults with complicated urinary...